GlassScriptPhysician profile
Stacey Apostol
NPI 1538921846
$2,370.16
in general payments reported to CMS, 2019-2025
13 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $686 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,370.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $640.71 | 2024-2025 | Dupixent |
| Digestive Care, INC. | $360.08 | 2024-2025 | Pertzye |
| Astrazeneca Pharmaceuticals LP | $320.47 | 2024-2025 | Fasenra, Tezspire |
| Philips North America LLC | $275.25 | 2024-2025 | Vest Therapy Und, (8874) Incourage, (Ak6) Vest Therapy |
| Genzyme Corporation | $166.15 | 2025 | |
| Baxter Healthcare | $161.41 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Vertex Pharmaceuticals Incorporated | $150.32 | 2024-2025 | |
| Abbvie INC. | $102.15 | 2024-2025 | |
| Amgen INC. | $86.82 | 2024-2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $50.53 | 2025 | Neffy |
| Pharming Healthcare, INC. | $25.49 | 2024 | Ruconest |
| Electromed, INC. | $17.44 | 2025 | Smartvest |
| Catalyst Pharmaceuticals, INC. | $13.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Apostol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.